Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Osteotech’s Plexur P granted FDA clearance
To date, the Plexur P Biocomposite has been used by a variety of surgeons in tibial plateau fractures, tibial osteotomies and a variety of foot and ankle procedures,
To date, the Plexur P Biocomposite has been used by a variety of surgeons in tibial plateau fractures, tibial osteotomies and a variety of foot and ankle procedures,
Mr Chicoyne will continue to work with the company and assist in transitional matters and in the completion of the company’s quarterly reporting process for the first quarter.
The new drug application filing for loratadine/montelukast was accepted by the FDA for standard review on August 26, 2007. The medicine is a single tablet that contains the
R7128, a prodrug of PSI-6130, is a nucleoside analogue polymerase inhibitor of HCV that is being developed through Pharmasset’s collaboration with Roche. In this study, R7128 demonstrated potent
The Office of Generic Drugs, FDA, has determined the Ohm formulation to be bioequivalent and have the same therapeutic effect as that of the reference listed drug children’s
R1626 also shows a high barrier to the development of resistance. After four weeks of treatment with this triple combination, followed by 44 weeks of Pegasys and Copegus,
A once-daily tablet, Viread works by blocking hepatitis B virus (HBV) DNA polymerase, the enzyme that is necessary for the virus to replicate in liver cells. This approval
The punitive damages were part of a 2004 decision of the California Court of Appeal which upheld a 2002 Los Angeles County Superior Court jury verdict awarding approximately
Under the terms of this new collaborative agreement, genOway will provide its client with both customized genetically modified mouse lines tailored to the researchers’s needs and ready-for-use animal
At a recent Pharmaceutical Pricing and Market Access Outlook meeting organized by Health Network Communications in London, Dr Longson said the new service is a major strategic development